The effect of treatment of hypercholesterolemia on risk of macular edema
Not Applicable
- Conditions
- Diabetes.E10, E11,Diabetes mellitus
- Registration Number
- IRCT201709207466N5
- Lead Sponsor
- Arak University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 82
Inclusion Criteria
Diabetic retinopathy; Borderline hypercholesterolemia; and having informed consent;
Exclusion Criteria
CSME macular edema; proliferative Diabetic retinopathy;
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Macular Edema. Timepoint: Baseline, 3 Months later. Method of measurement: Test.
- Secondary Outcome Measures
Name Time Method Retinopathy. Timepoint: Baseline, 3 months Later. Method of measurement: Test.